Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Revenue | $23.26M | $21.25M | $22.61M | $18.44M |
| Net Income | $7.82M | $6.65M | $4.46M | $2.88M |
| EPS Diluted | $0.51 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.44 |
| $0.31 |
| $0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
